BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1733 related articles for article (PubMed ID: 26757898)

  • 1. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets.
    Solanki NG; Kathawala M; Serajuddin ATM
    J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of hot melt extrusion and spray drying on mechanical properties and tableting indices of materials used in pharmaceutical development.
    Iyer R; Hegde S; Zhang YE; Dinunzio J; Singhal D; Malick A; Amidon G
    J Pharm Sci; 2013 Oct; 102(10):3604-13. PubMed ID: 23955277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
    Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
    Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.
    Agrawal AM; Dudhedia MS; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):133-47. PubMed ID: 26729533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hot Melt Extrudates Formulated Using Design Space: One Simple Process for Both Palatability and Dissolution Rate Improvement.
    Malaquias LFB; Schulte HL; Chaker JA; Karan K; Durig T; Marreto RN; Gratieri T; Gelfuso GM; Cunha-Filho M
    J Pharm Sci; 2018 Jan; 107(1):286-296. PubMed ID: 28847477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-line monitoring of compaction properties on a rotary tablet press during tablet manufacturing of hot-melt extruded amorphous solid dispersions.
    Grymonpré W; Verstraete G; Van Bockstal PJ; Van Renterghem J; Rombouts P; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2017 Jan; 517(1-2):348-358. PubMed ID: 27988376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of disintegrants functionality for orodispersible mini tablets.
    Soulairol I; Chaheen M; Tarlier N; Aubert A; Bataille B; Sharkawi T
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1770-1779. PubMed ID: 28581832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
    Zaheer K; Langguth P
    Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
    Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
    J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.
    LaFountaine JS; Prasad LK; Brough C; Miller DA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):120-32. PubMed ID: 26729526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of the Polymer Type on the Quality of Newly Developed Oral Immediate-Release Tablets Containing Amiodarone Solid Dispersions Obtained by Hot-Melt Extrusion.
    Fița AC; Secăreanu AA; Musuc AM; Ozon EA; Sarbu I; Atkinson I; Rusu A; Mati E; Anuta V; Pop AL
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional assessment of four types of disintegrants and their effect on the spironolactone release properties.
    Rojas J; Guisao S; Ruge V
    AAPS PharmSciTech; 2012 Dec; 13(4):1054-62. PubMed ID: 22899380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified formulations with high drug loads for continuous twin-screw granulation.
    Meier R; Thommes M; Rasenack N; Krumme M; Moll KP; Kleinebudde P
    Int J Pharm; 2015 Dec; 496(1):12-23. PubMed ID: 26024821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of disintegrants in different substrate physical form on dimensional recovery of multi-component tablet.
    Sarkar S; Ooi SM; Liew CV; Tan BX; Heng PW
    Int J Pharm; 2014 Nov; 475(1-2):558-65. PubMed ID: 25218488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 87.